Cognitive Impairment Associated with Chemotherapy in Breast Cancer Patients
Conditions
Interventions
Sponsors
Beijing Hospital of Traditional Chinese Medicine,Capital Medical University
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Breast cancer patients aged 25-55 years after chemotherapy; 2. Patients with mild cognitive impairment diagnosed according to the Montreal Assessment scale (MoCA) are rated between 21 and 26 (including 21 and 26); 3. Syndrome differentiation of TCM belongs to QiXueShiTiao type.
Exclusion criteria
Exclusion criteria: 1. People with cognitive impairment caused by depression, thyroid disease, brain trauma, drug or alcohol poisoning; 2. People with severe aphasia, depression, mental illness; 3. Patients with cognitive impairment associated with severe heart, liver, lung, and renal dysfunction and severe primary disease of hematopoietic system and endocrine system; 4. Person who takes drugs that affect cognitive function (eg poison, narcotic, tranquilizer, etc.); 5. Meet the diagnostic criteria of dementia.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Montreal Cognitive Assessment scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Simple intelligence examination method;Quality of life measurement scale; | — |
Countries
China
Contacts
Public ContactQing Zhang
Beijing Hospital of Traditional Chinese Medicine,Capital Medical University
Outcome results
None listed